Increasing Investments and Fundings in Cell and Gene Therapy Fuelling the Growth of Cell and Gene Therapy Biomanufacturing, Suggests BIS Research Study
FREMONT, Calif., March 24, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis.
- FREMONT, Calif., March 24, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis.
- According to this study, the global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is projected to reach $29.76 billion by 2031.
- Therefore, the impact of the aforementioned factors is expected to drive the global cell and gene therapy biomanufacturing market in the near future."
- The software solutions segment consists of all the software utilized from manufacturing to logistics in cell and gene therapy biomanufacturing.